Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease.

[1]  K. Ley,et al.  P-selectin Glycoprotein Ligand-1 Mediates L-Selectin–dependent Leukocyte Rolling in Venules , 2003, The Journal of experimental medicine.

[2]  W. Hagmann,et al.  VLA‐4 antagonists: Potent inhibitors of lymphocyte migration , 2003, Medicinal research reviews.

[3]  P. Elliott,et al.  Proteasome inhibition: a new anti-inflammatory strategy , 2003, Journal of Molecular Medicine.

[4]  S. Bodary,et al.  Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection , 2003, Expert opinion on biological therapy.

[5]  M. Schön,et al.  Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders? , 2003, Trends in pharmacological sciences.

[6]  Subrata Ghosh,et al.  Natalizumab for active Crohn's disease. , 2003, The New England journal of medicine.

[7]  David H. Miller,et al.  A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.

[8]  G. Wolff,et al.  Development of Synthetic Pan-Selectin Antagonists: A New Treatment Strategy for Chronic Inflammation in Asthma , 2003, Pathobiology.

[9]  J. Mocco,et al.  HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke , 2002, Circulation research.

[10]  N. Kaila,et al.  Design and synthesis of sialyl Lewisx mimics as E‐ and P‐selectin inhibitors , 2002, Medicinal research reviews.

[11]  R. Gibbons,et al.  The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. , 2002, Journal of the American College of Cardiology.

[12]  R. Horuk,et al.  Chemokines, chemokine receptors and small-molecule antagonists: recent developments. , 2002, Trends in pharmacological sciences.

[13]  G. Weitz-Schmidt,et al.  Statins as anti-inflammatory agents. , 2002, Trends in pharmacological sciences.

[14]  N. Hogg,et al.  Mechanisms contributing to the activity of integrins on leukocytes , 2002, Immunological reviews.

[15]  Michael Loran Dustin,et al.  The immunological synapse: integrins take the stage , 2002, Immunological reviews.

[16]  J. Lowe.  Glycosylation in the control of selectin counter‐receptor structure and function , 2002, Immunological reviews.

[17]  Junichi Takagi,et al.  Integrin activation and structural rearrangement , 2002, Immunological reviews.

[18]  P. Rutgeerts,et al.  Antiadhesion molecule therapy in inflammatory bowel disease. , 2002, Inflammatory bowel diseases.

[19]  D. Sutherlin,et al.  Selective α4β7 Integrin Antagonists and Their Potential as Antiinflammatory Agents , 2002 .

[20]  M. Perretti,et al.  Regulation of Leukocyte‐Endothelial Interactions by Glucocorticoids , 2002, Annals of the New York Academy of Sciences.

[21]  David Y Jackson,et al.  Alpha 4 integrin antagonists. , 2002, Current pharmaceutical design.

[22]  A. Milici,et al.  Pulmonary Eosinophilia in a Murine Model of Allergic Inflammation Is Attenuated by Small Molecule α4β1 Antagonists , 2002 .

[23]  J. Harlan,et al.  Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy , 2002, Critical care medicine.

[24]  C. Griffiths,et al.  Anti‐E‐selectin is ineffective in the treatment of psoriasis: a randomized trial , 2002, The British journal of dermatology.

[25]  W. Muller,et al.  Leukocyte-Endothelial Cell Interactions in the Inflammatory Response , 2002, Laboratory Investigation.

[26]  H. Gollnick,et al.  Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation , 2002, Nature Medicine.

[27]  R. Cummings,et al.  P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. , 2002, The Journal of clinical investigation.

[28]  Helena Yusuf-Makagiansar,et al.  Inhibition of LFA‐1/ICAM‐1 and VLA‐4/VCAM‐1 as a therapeutic approach to inflammation and autoimmune diseases , 2002, Medicinal research reviews.

[29]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[30]  M. Díaz-Ricart,et al.  Treatment of acute myocardial infarction thrombolytic P-selectin inhibitor , 2002 .

[31]  G. Zimmerman,et al.  Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. , 2002, Current opinion in hematology.

[32]  R. Gibbons,et al.  Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study , 2001, Circulation.

[33]  Enlimomab Acute Stroke Trial Investigators.  Use of anti-ICAM-1 therapy in ischemic stroke , 2001, Neurology.

[34]  L. Kifle,et al.  Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamides. , 2001, Journal of medicinal chemistry.

[35]  E B Reilly,et al.  Discovery of potent antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 3. Amide (C-ring) structure-activity relationship and improvement of overall properties of arylthio cinnamides. , 2001, Journal of medicinal chemistry.

[36]  L. Lindbom,et al.  Importance of Primary Capture and L-Selectin–Dependent Secondary Capture in Leukocyte Accumulation in Inflammation and Atherosclerosis in Vivo , 2001, The Journal of experimental medicine.

[37]  Romano Sj,et al.  Targeting selectins for the treatment of respiratory diseases. , 2001 .

[38]  J. Marth,et al.  Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase-deficient mice. , 2001, Blood.

[39]  D. Slee,et al.  Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity. , 2001, Journal of medicinal chemistry.

[40]  F. Sánchez‐Madrid,et al.  Drugs, inflammation and cell adhesion receptors , 2001, Expert opinion on pharmacotherapy.

[41]  G. Liu.  Inhibitors of LFA-1/ICAM-1 interaction: From monoclonal antibodies to small molecules , 2001 .

[42]  K. Ley,et al.  Functions of selectins. , 2001, Results and problems in cell differentiation.

[43]  K. Ley.  Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants , 2001, Immunologic research.

[44]  R. Dixon,et al.  Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. , 2000, American journal of physiology. Heart and circulatory physiology.

[45]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[46]  P. Rieu,et al.  Neutrophils: Molecules, Functions and Pathophysiological Aspects , 2000, Laboratory Investigation.

[47]  D. Lefer.  Pharmacology of selectin inhibitors in ischemia/reperfusion states. , 2000, Annual review of pharmacology and toxicology.

[48]  B. Furie,et al.  Targeted Gene Disruption Demonstrates That P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Required for P-Selectin–Mediated but Not E-Selectin–Mediated Neutrophil Rolling and Migration , 1999, The Journal of experimental medicine.

[49]  P. Reilly,et al.  Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesion. , 1999, Journal of immunology.

[50]  C. Lowell,et al.  Integrin signalling in neutrophils and macrophages. , 1999, Cellular signalling.

[51]  R. B. Pepinsky,et al.  Selective, tight-binding inhibitors of integrin α4β1 that inhibit allergic airway responses , 1999 .

[52]  D. Vestweber,et al.  Mechanisms that regulate the function of the selectins and their ligands. , 1999, Physiological reviews.

[53]  T. Richards,et al.  Phase I study of a humanized anti‐CD11/CD18 monoclonal antibody in multiple sclerosis , 1998, Clinical pharmacology and therapeutics.

[54]  R. Dixon,et al.  Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269). , 1998, Journal of medicinal chemistry.

[55]  E. Butcher,et al.  Molecular Mechanisms of Lymphocyte Homing to Peripheral Lymph Nodes , 1998, The Journal of experimental medicine.

[56]  E. Berg,et al.  α4 integrins mediate lymphocyte attachment and rolling under physiologic flow , 1995, Cell.

[57]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[58]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[59]  S. Watson,et al.  The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide , 1992, The Journal of cell biology.